Grip Strength Test: When to Order, What It Means, and Normal Ranges

What Grip Strength Actually Measures

Grip strength quantifies the maximum isometric force generated when squeezing a calibrated hand dynamometer. The test reflects more than hand and forearm muscle function. It serves as a proxy for total-body skeletal muscle quality, neuromuscular integrity, and nutritional status 1.

Why a Simple Squeeze Predicts So Much

Skeletal muscle accounts for roughly 40% of body mass, and the hand contains 34 muscles innervated by the median and ulnar nerves. A weak grip signals systemic muscle wasting, chronic inflammation, or hormonal deficiency long before a patient reports difficulty climbing stairs or opening jars. The 2019 European Working Group on Sarcopenia in Older People (EWGSOP2) consensus identified grip strength as the first-line measure for confirming low muscle strength, placing it ahead of imaging and even ahead of gait speed in the diagnostic algorithm 1.

The Mortality Signal

The PURE (Prospective Urban Rural Epidemiology) study followed 139,691 adults across 17 countries for a median of four years. Each 5 kg reduction in grip strength was associated with a 17% increase in all-cause mortality (HR 1.16, 95% CI 1.13 to 1.20) and a 7% increase in the risk of myocardial infarction 2. Grip strength outperformed systolic blood pressure as a predictor of death. That finding, published in The Lancet by Leong et al. In 2015, changed the way many internists think about functional testing.

When to Order a Grip Strength Test

A grip strength measurement should be ordered in any clinical scenario where muscle function, nutritional status, or physical resilience needs quantification. The test is cheap, fast, and validated across dozens of populations 3.

Sarcopenia Screening in Adults Over 60

The EWGSOP2 algorithm recommends using the SARC-F questionnaire as a first filter, followed by grip strength measurement to confirm "probable sarcopenia." If grip strength falls below 27 kg in men or below 16 kg in women, the diagnosis of probable sarcopenia is established and further workup (DXA or BIA for muscle mass) is warranted 1. The International Conference on Sarcopenia and Frailty Research (ICSFR) endorsed this approach in its 2018 clinical practice guidelines 4.

Preoperative and Perioperative Risk Assessment

Low grip strength independently predicts postoperative complications, longer hospital stays, and 30-day readmission. A 2016 meta-analysis by Bohannon found that patients with grip strength below the 10th percentile for their age had a 2.3-fold higher risk of in-hospital mortality after major abdominal surgery 5. Surgeons and anesthesiologists increasingly request dynamometry as part of prehabilitation protocols.

Chronic Disease Monitoring

Grip strength declines faster than expected in patients with type 2 diabetes, COPD, heart failure, chronic kidney disease, and cancer. In the Health ABC Study (N=3,075), participants with diabetes lost grip strength 1.5 to 2 times faster per year than those without diabetes, even after adjustment for body composition 6. Tracking grip over time can reveal functional deterioration that lab values and imaging miss.

Frailty Phenotype Assessment

Linda Fried's original frailty phenotype, published in the Journals of Gerontology in 2001, lists low grip strength as one of five criteria (alongside weight loss, exhaustion, slow walking speed, and low physical activity). Meeting three or more criteria defines frailty; meeting one or two defines pre-frailty 7. This remains the most widely cited frailty model in geriatric medicine.

Nutritional and Hormonal Assessment

Testosterone deficiency, growth hormone deficiency, and protein-energy malnutrition all reduce grip strength. In men on testosterone replacement therapy (TRT), dynamometry can serve as a functional biomarker of response. The Testosterone Trials (TTrials) showed that one year of testosterone gel improved grip strength by a mean of 1.3 kg compared to placebo in men aged 65 and older with low testosterone 8.

Normal Grip Strength Ranges by Age and Sex

Reference values depend on age, sex, hand dominance, and the device used. The most widely cited normative dataset comes from Bohannon's 2019 systematic review, which pooled data from 53 studies and over 200,000 participants 9.

Men: Expected Ranges

| Age Range | Right Hand (kg) | Left Hand (kg) | |-----------|-----------------|-----------------| | 20 to 29 | 46 to 54 | 42 to 50 | | 30 to 39 | 45 to 53 | 41 to 49 | | 40 to 49 | 43 to 51 | 39 to 47 | | 50 to 59 | 39 to 47 | 35 to 44 | | 60 to 69 | 33 to 43 | 30 to 40 | | 70 to 79 | 28 to 38 | 25 to 35 | | 80+ | 22 to 31 | 19 to 28 |

Women: Expected Ranges

| Age Range | Right Hand (kg) | Left Hand (kg) | |-----------|-----------------|-----------------| | 20 to 29 | 29 to 34 | 26 to 31 | | 30 to 39 | 28 to 34 | 25 to 31 | | 40 to 49 | 27 to 33 | 24 to 30 | | 50 to 59 | 24 to 30 | 22 to 28 | | 60 to 69 | 21 to 27 | 19 to 25 | | 70 to 79 | 18 to 24 | 16 to 22 | | 80+ | 14 to 20 | 12 to 18 |

These values represent the 25th to 75th percentile range. A result below the 10th percentile for age and sex warrants clinical attention. The EWGSOP2 thresholds (men: <27 kg, women: <16 kg) are deliberately set low to identify individuals with clearly pathological weakness rather than normal age-related decline 1.

How the Test Is Performed

Standardized measurement protocol matters. A 2019 systematic review in the Journal of Cachexia, Sarcopenia, and Muscle found that non-standardized testing positions produced up to 12% variation in results 10.

Standard Protocol (American Society of Hand Therapists)

The patient sits with the shoulder adducted, the elbow flexed at 90 degrees, and the forearm in a neutral position. The Jamar dynamometer (or a validated alternative such as the DynEx or Saehan device) is set to handle position II. The patient squeezes maximally for three to five seconds. Three trials are performed with 30 to 60 seconds of rest between each trial. The highest value is recorded.

Common Pitfalls

Body position affects results significantly. Standing increases grip strength by approximately 3 to 5%. Testing with the elbow extended rather than flexed at 90 degrees can change values by up to 10% 10. Time of day also matters. Grip strength peaks between 14:00 and 18:00 and is lowest before 08:00. For serial monitoring, test at the same time and in the same position.

Dr. John Morley, former editor of the Journal of the American Medical Directors Association, has stated: "Grip strength is the simplest, most cost-effective measure of health span we possess. Every geriatric assessment should include it" 4.

What Low Grip Strength Means

A result below the EWGSOP2 cutoff (men: <27 kg, women: <16 kg) signals probable sarcopenia and demands further evaluation. Low grip strength is not a diagnosis. It is a gateway finding.

Differential Diagnosis

Low values can reflect generalized sarcopenia (age-related muscle loss), disuse atrophy from prolonged bed rest or sedentary behavior, malnutrition (particularly protein deficiency), endocrine disorders (hypogonadism, hypothyroidism, growth hormone deficiency, Cushing syndrome), neuromuscular disease (carpal tunnel syndrome, cervical radiculopathy, peripheral neuropathy), or inflammatory conditions (rheumatoid arthritis, polymyalgia rheumatica).

Next Steps After a Low Result

The EWGSOP2 pathway directs clinicians to measure appendicular skeletal muscle mass (ASM) by DXA or bioelectrical impedance analysis. If ASM is also low (men: <20 kg, women: <15 kg by DXA), sarcopenia is confirmed. Adding a gait speed measurement (below 0.8 m/s indicates severe sarcopenia) completes the staging 1.

Lab testing should include serum 25-hydroxyvitamin D, total testosterone (in men), TSH, albumin, CRP, and HbA1c. These identify reversible contributors to muscle loss.

What High Grip Strength Means

High grip strength (above the 75th percentile for age and sex) is consistently associated with lower mortality, better cognitive function, and fewer cardiovascular events. In a UK Biobank analysis of 502,293 adults, each standard deviation increase in grip strength was linked to a 14% reduction in all-cause mortality (HR 0.86, 95% CI 0.84 to 0.88) 11.

Upper Limits and Context

There is no pathological upper limit for grip strength. Extremely high values (men above 65 kg, women above 42 kg) typically reflect occupational or athletic training. They require no clinical workup unless the patient reports hand pain or unilateral weakness.

How to Improve Grip Strength

Resistance training is the only intervention with consistent, high-quality evidence for increasing grip strength. Two approaches stand out.

Progressive Resistance Training

A 2021 Cochrane review of 73 trials (N=5,762) in adults over 65 found that progressive resistance training increased grip strength by a mean of 2.8 kg (95% CI 1.9 to 3.7) over 12 to 24 weeks 12. Effective protocols used two to three sessions per week, with exercises targeting the whole body (not just the forearm). Compound movements like deadlifts, rows, and farmer carries produced the largest grip improvements because they load the hand under progressive resistance.

Specific Grip Training

Isolated grip work (spring-loaded hand grippers, rice bucket exercises, towel hangs) can add 1 to 3 kg over eight weeks in younger adults. These modalities are useful as supplements but do not replace whole-body strength training for older adults with sarcopenia.

Nutritional and Hormonal Interventions

Adequate protein intake (1.0 to 1.2 g per kg body weight per day, per ESPEN guidelines for older adults) supports muscle protein synthesis 13. Vitamin D supplementation in deficient individuals (25-OH-D below 20 ng/mL) may modestly improve muscle function. Testosterone replacement in hypogonadal men improves grip by approximately 1 to 3 kg based on TTrials data 8.

What Causes Grip Strength to Decline

Grip strength peaks between ages 25 and 35 and then declines at roughly 1 to 2% per year. After age 50, the rate accelerates. By age 80, the average man retains about 55% of his peak grip, and the average woman retains about 50%.

Modifiable Factors

Physical inactivity is the largest modifiable contributor. Hospitalized patients lose approximately 3 to 5% of grip strength per week of bed rest 5. Other modifiable causes include low protein intake, uncontrolled diabetes, untreated hypothyroidism, vitamin D deficiency, excessive alcohol use, and chronic corticosteroid therapy.

Non-Modifiable Factors

Age-related motor neuron loss, type II fiber atrophy, and declining anabolic hormone levels all contribute to sarcopenia independent of lifestyle. Genetic studies suggest that 30 to 65% of the variance in grip strength is heritable 11.

How Often to Retest

No consensus guideline specifies a universal retesting interval. Practical recommendations based on clinical context:

• Sarcopenia monitoring in community-dwelling older adults: every 6 to 12 months.
• Perioperative assessment: once preoperatively, then at 4 to 6 weeks post-discharge.
• Chronic disease (diabetes, CKD, COPD, cancer): every 3 to 6 months during active treatment or disease progression.
• TRT or GH replacement monitoring: at baseline, 3 months, and 6 months, then annually.

A decline of more than 5 kg over 12 months, or a drop below the EWGSOP2 threshold, should trigger a comprehensive sarcopenia evaluation.

The ICSFR clinical practice guidelines state: "Grip strength should be measured routinely in clinical settings for older adults, much as blood pressure and body weight are measured at every visit" 4.